Provided by Tiger Trade Technology Pte. Ltd.

iShares U.S. Healthcare ETF

70.87
+0.95001.36%
Volume:1.34M
Turnover:95.15M
Market Cap:3.68B
PE:6.38
High:71.25
Open:70.93
Low:70.59
Close:69.92
52wk High:74.59
52wk Low:56.44
Shares:51.90M
Float Shares:51.90M
Volume Ratio:3.71
T/O Rate:2.59%
Dividend:0.80
Dividend Rate:1.13%
EPS(TTM):11.10
EPS(LYR):3.06
ROE:6.01%
ROA:0.87%
PB:1.31
PE(LYR):23.17

Loading ...

Johnson & Johnson Says Subcutaneous Cancer Treatment Study Shows Low Rates Across Key Events, Discontinuation

MT Newswires Live
·
27 mins ago

Testosterone Scripts for Women Rise, Along with Denials and Delays

Reuters
·
36 mins ago

Berenberg Upgrades Eli Lilly and Co. to Buy From Hold, Adjusts Price Target to $1,400 From $1,220

MT Newswires Live
·
1 hour ago

Barclays downgrades Scholar Rock on valuation after FDA approval

TIPRANKS
·
1 hour ago

Lilly Gains After Berenberg Upgrades to 'buy' on Obesity Pill Momentum

Reuters
·
2 hours ago

U.S. Research Roundup- Eli Lilly, McDonald's, Welltower

Reuters
·
3 hours ago

Eli Lilly : Berenberg Raises to Buy from Hold; Raises Target Price to $1,400 from $1,220

THOMSON REUTERS
·
5 hours ago

JNJ Reports Low Rates of Treatment-Related Events for Rybrevant Faspro Plus Lazcluze at Wclc 2026

Reuters
·
7 hours ago

J&J - Fewer than 1% Discontinue Rybrevant Faspro Plus Lazcluze Due to Treatment-Related Events at One Year

THOMSON REUTERS
·
7 hours ago

RBC Capital Sticks to Their Hold Rating for Merck & Company (MRK)

TIPRANKS
·
8 hours ago

RBC Capital Sticks to Their Buy Rating for Eli Lilly & Co (LLY)

TIPRANKS
·
8 hours ago

Contineum Therapeutics Says Phase 2 Major Depressive Disorder Study Fails to Meet Primary Efficacy Endpoint

MT Newswires Live
·
13 hours ago

Medtronic PLC Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
13 hours ago

Contineum Therapeutics Shares Fall After Drug Trial Missed Primary Endpoint

Dow Jones
·
13 hours ago

Lilly Says Foundayo Has Captured over 30% of New US Patients on Oral Weight-Loss Drugs

Reuters
·
14 hours ago

AbbVie Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
14 hours ago

Contineum, J&J's Depression Drug Fails to Meet Mid-Stage Trial Goal

Reuters
·
14 hours ago

Contineum Therapeutics, - Johnson & Johnson Continues to Evaluate Trial Data for Jnj-5120/Pipe-307

THOMSON REUTERS
·
14 hours ago

Merck & Co Exec Says Potential 340B and Policy Evolutions Would Create Tailwinds but are not Material to the Business - Morgan Stanley Conf

THOMSON REUTERS
·
15 hours ago

Merck & Co Exec Says Timing for Raising the $70 Bln Forecast is "to be Determined" Adds "It's Coming"

THOMSON REUTERS
·
15 hours ago